Dorsey Wright & Associates Cara Therapeutics, Inc. Transaction History

Dorsey Wright & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$16.11 - $25.98 $9,150 - $14,756	-568 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$18.28 - $26.91 $36 - $53	2 Added 0.35%	568 $10,000
Q2 2019 Jul 02, 2019	BUY	$17.68 - $21.57 $2,492 - $3,041	141 Added 33.18%	566 $12,000
Q1 2019 Apr 04, 2019	SELL	$14.41 - $19.64 $6,095 - $8,307	-423 Reduced 49.88%	425 $8,000
Q4 2018 Jan 07, 2019	BUY	$12.45 - $23.47 $10,557 - $19,902	848 New	848 $11,000

16.5M

55K

500

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.1M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.